Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To evaluate the safety and tolerability of AT9283 (given by intravenous (IV) infusion) by characterising the dose limiting toxicities (DLTs) and determining a maximum tolerated dose (MTD) in children and adolescents with relapsed and refractory solid tumours.
Critère d'inclusion
- Relapsed and refractory solid tumours in children and adolescents